Home    Back

 Drug    DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, Adalimumab

ABCDEFGH I JKLMNOPQRSTUVWXYZother

4 / 2,001 drugs

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 Disease ID
 1  Cholecalciferol [11] 5000 iu of cholecalciferol; Calcium and cholecalciferol; Cholecalciferol; Cholecalciferol (vitamin d3); Cholecalciferol (vitamind3); Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol and c. xanthorrhiza; Cholecalciferol concentrate; Cholecalciferol concentrate (water-dispersible form); Cholecalciferol, vitamin d3;  [1] D00188 💬 [1] VDR 💬 [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis  [23]  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
 2  Melatonin [11] 3 mg melatonin; 5 mg melatonin; Circadin ( inn= melatonin); Diazepam, melatonin; Dtr melatonin (nih cc pds); Hourly dosing of the nychtemeral secretion of melatonin; Melatonin; Melatonin cr; Melatonin pr; Melatonin(circadin®); Other: review of past medical history, clinical exam, and electroencephalogram, polysomnography and urine samples of melatonin and pupillometry.;  [1] D08170 💬 [2] MTNR1A, MTNR1B 💬 [2] Circadian entrainment, Neuroactive ligand-receptor interaction  [11]  6 ,  8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
 3  Setmelanotide [1] Setmelanotide;  [1] D11927 💬 [1] MC4R 💬 [1] Neuroactive ligand-receptor interaction  [2] 202, 265 💬
 4  Tasimelteon [1] Tasimelteon;  [1] D09388 💬 [2] MTNR1A, MTNR1B 💬 [2] Circadian entrainment, Neuroactive ligand-receptor interaction  [1] 202 💬